Search company, investor...

Founded Year

2005

Stage

IPO | IPO

Total Raised

$164.58M

Date of IPO

5/1/2020

Market Cap

0.26B

Stock Price

5.00

About Lyra Therapeutics

Lyra Therapeutics is a clinical-stage biotechnology company with a focus on developing innovative therapies in the healthcare sector. The company's main service is the creation of therapies for the localized treatment of chronic rhinosinusitis (CRS), a debilitating inflammatory disease, with the aim of providing long-lasting treatment options. Lyra Therapeutics primarily serves the healthcare industry, specifically targeting patients suffering from CRS. Lyra Therapeutics was formerly known as Arsenal Medical, Inc.. It was founded in 2005 and is based in Watertown, Massachusetts.

Headquarters Location

480 Arsenal Street

Watertown, Massachusetts, 02472,

United States

617-393-4600

Loading...

Loading...

Lyra Therapeutics Patents

Lyra Therapeutics has filed 44 patents.

The 3 most popular patent topics include:

  • bones of the head and neck
  • inflammations
  • animal virology
patents chart

Application Date

Grant Date

Title

Related Topics

Status

4/3/2020

5/23/2023

Bones of the head and neck, Inflammations, Glucocorticoids, Drug delivery devices, Dosage forms

Grant

Application Date

4/3/2020

Grant Date

5/23/2023

Title

Related Topics

Bones of the head and neck, Inflammations, Glucocorticoids, Drug delivery devices, Dosage forms

Status

Grant

Lyra Therapeutics Frequently Asked Questions (FAQ)

  • When was Lyra Therapeutics founded?

    Lyra Therapeutics was founded in 2005.

  • Where is Lyra Therapeutics's headquarters?

    Lyra Therapeutics's headquarters is located at 480 Arsenal Street, Watertown.

  • What is Lyra Therapeutics's latest funding round?

    Lyra Therapeutics's latest funding round is IPO.

  • How much did Lyra Therapeutics raise?

    Lyra Therapeutics raised a total of $164.58M.

  • Who are the investors of Lyra Therapeutics?

    Investors of Lyra Therapeutics include North Bridge Venture Partners, InterSouth Partners, Polaris Partners, RA Capital Management, ArrowMark Partners and 9 more.

  • Who are Lyra Therapeutics's competitors?

    Competitors of Lyra Therapeutics include Relievant Medsystems, Embolx, Tepha, Mobius Therapeutics, Belmont Instrument and 7 more.

Loading...

Compare Lyra Therapeutics to Competitors

C
C2C

C2C specializes in the contract manufacturing of medical devices, offering comprehensive services from product development to commercialization. The company provides expertise in design, prototyping, regulatory strategy, and pilot production, as well as manufacturing, packaging, labeling, and sterilization of medical devices. C2C primarily serves the medical device industry, catering to inventors and companies seeking to bring new products to market or scale existing ones. It is based in Melbourne, Florida.

Belmont Instrument Logo
Belmont Instrument

Belmont Medical Technologies specializes in the development of medical devices for fluid management and critical care within the healthcare sector. The company offers a range of products including blood and fluid warming devices, temperature management systems, and hyperthermic lavage equipment designed to improve patient outcomes in various medical settings. These products are primarily utilized in areas such as anesthesia, emergency transport, intensive care, labor and delivery, military applications, surgical care, and trauma and emergency situations. It was founded in 1980 and is based in Billerica, Massachusetts.

Femeda Logo
Femeda

Femeda is a company focused on improving the quality of life for women by developing medical devices in the female health sector. Their main product, Pelviva, is a pelvic floor muscle trainer designed to treat urinary incontinence in women through a program of muscle stimulation. Femeda primarily sells to the healthcare, pharmacy, and pharmaceutical sectors. It is based in United Kingdom.

Embolx Logo
Embolx

Embolx is a medical device company that focuses on the development of microcatheters for arterial embolization procedures. The company's main products are devices that aid in the treatment of various conditions such as cancerous tumors, benign prostatic hyperplasia, and uterine fibroids by controlling blood flow and protecting non-target tissues. It was founded in 2013 and is based in Sunnyvale, California. Embolx operates as a subsidiary of Edwards Lifesciences.

N
NDO Surgical

Medical devices for the treatment of severe gastrointestinal disorders

E
EMCOOLS-Emergency Medical Cooling Systems

EMCOOLS-Emergency Medical Cooling Systems specializes in non-invasive body cooling technologies within the healthcare sector. The company offers a range of cooling products including full body suits, pads, and suits designed for targeted temperature management, heat stroke treatment, cryotherapy, and personal cooling. These products are utilized by various sectors including hospitals, emergency medical services, and hazardous materials personnel. It is based in Austria.

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.